Oncotarget
The cover for issue 15 of Oncotarget features Figure 6, "A schematic diagram illustrating the likely mechanism(s) of the TSPX-mediated suppression of the MYC gene," by Kido, et al.
mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development |
https://doi.org/10.18632/oncotarget.26668 Laura Molina, Hong Yang, Adeola O. Adebayo Michael, Michael Oertel, Aaron Bell, Sucha Singh, Xin Chen, Junyan Tao, and Satdarshan P.S. Monga |
1475-1490 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
The X-linked tumor suppressor TSPX downregulates cancer-drivers/oncogenes in prostate cancer in a C-terminal acidic domain dependent manner |
https://doi.org/10.18632/oncotarget.26673 Tatsuo Kido, Yunmin Li, Yuichiro Tanaka, Rajvir Dahiya, and Yun-Fai Chris Lau |
1491-1506 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
TGF-β inducible epithelial-to-mesenchymal transition in renal cell carcinoma |
https://doi.org/10.18632/oncotarget.26682 Sandy Tretbar, Peter Krausbeck, Anja Müller, Michael Friedrich, Christoforos Vaxevanis, Juergen Bukur, Simon Jasinski-Bergner, and Barbara Seliger |
1507-1524 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
POPX2 is a novel LATS phosphatase that regulates the Hippo pathway |
https://doi.org/10.18632/oncotarget.26689 Muhammad Bakhait Rahmat, Songjing Zhang, and Cheng-Gee Koh |
1525-1538 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy |
https://doi.org/10.18632/oncotarget.26723 Jian Cui, Lin Yang, Lei Guo, Yongfu Shao, Dongfeng Tan, Ni Li, and Haizeng Zhang |
1539-1539 |
Correction | PDF | How to cite |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC